Neuland Laboratories Ltd

Surging past its previous peaks, Neuland Laboratories Ltd touched an all-time high of Rs 22,499.95 on 7 Aug 2026, marking a remarkable 74.61% gain over the past year. This rally is underpinned by a confluence of strong technical indicators and sustained price momentum, even as the broader Sensex trades lower.

Neuland Laboratories Ltd has reached a significant milestone by touching its all-time high price of Rs 22,450 on 07 Aug 2026, reflecting a strong upward trajectory driven by consistent financial growth and solid market performance.

Neuland Laboratories Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 01 June 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 07 August 2026, providing investors with the most up-to-date insight into the company’s performance and outlook.

Neuland Laboratories Ltd, a prominent player in the Pharmaceuticals & Biotechnology sector, witnessed a remarkable surge in trading activity on 6 August 2026, driven by substantial value turnover and heightened institutional participation. The stock outperformed its sector peers and broader market indices, reflecting renewed investor confidence and robust market dynamics.

Surging past its previous peaks, Neuland Laboratories Ltd touched a new 52-week high of Rs 21,850 on 6 Aug 2026, propelled by a confluence of robust technical indicators and sustained price momentum that has captivated market attention.

The Sensex edged up 0.23% on 6 Aug 2026, while Neuland Laboratories Ltd surged 7.95%, reaching an intraday high of Rs 21,850. This 6.96-percentage-point outperformance over its Pharmaceuticals & Biotechnology sector peers highlights a distinctly stock-specific rally rather than a broad market lift.

Neuland Laboratories Ltd commenced trading on 6 August 2026 with a significant gap up, opening 6.54% higher than the previous close. This robust start was accompanied by a day gain of 7.85%, underscoring a positive market response and sustained momentum throughout the session.

Extending its recent rally, Neuland Laboratories Ltd surged to a fresh all-time high of Rs 21,850 on 6 Aug 2026, outperforming its sector and the broader market with a robust 6.82% gain on the day.

Neuland Laboratories Ltd., a Hyderabad-based pharmaceutical manufacturer specialising in active pharmaceutical ingredients (APIs), has delivered a stunning Q1 FY27 performance with net profit surging 962.37% year-on-year to ₹147.67 crores, though the sequential decline of 30.56% from Q4 FY26's exceptional ₹212.67 crores raises questions about sustainability. The ₹25,414-crore market capitalisation company saw its stock rally 3.51% to ₹19,964.70 following the results announcement, trading near its 52-week high of ₹20,100.00 and reflecting investor optimism about the pharma sector's recovery trajectory.

With a 56.7% gain over the past year, Neuland Laboratories Ltd has surged to a fresh 52-week high of Rs 20,072 on 5 Aug 2026, outpacing the Sensex which declined by 2.6% over the same period. This milestone caps a sustained rally fuelled by a confluence of strong technical signals and robust quarterly earnings growth.

Neuland Laboratories Ltd has reached a significant milestone by touching an all-time high price of ₹20,052 on 5 August 2026, reflecting a strong upward trajectory driven by impressive financial results and sustained growth across key metrics.

Neuland Laboratories Ltd is rated Buy by MarketsMOJO, with this rating last updated on 01 June 2026. However, all fundamentals, returns, and financial metrics discussed here reflect the stock’s current position as of 27 July 2026, providing investors with the latest insights into the company’s performance and outlook.

Neuland Laboratories Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 01 June 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 16 July 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and technical outlook.

Surging past its previous peaks, Neuland Laboratories Ltd touched a fresh 52-week high of Rs 19,800 on 9 Jul 2026, marking a remarkable 66.16% gain over the past year. This milestone comes amid a backdrop of strong technical momentum and robust quarterly earnings growth, setting the stage for a sustained uptrend.

Neuland Laboratories Ltd has reached a significant milestone by touching an all-time high price of ₹19,739.40 on 09 Jul 2026, reflecting a strong upward trajectory supported by impressive financial results and sustained growth across multiple metrics.

Neuland Laboratories Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 01 June 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 05 July 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market performance.

Neuland Laboratories Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 01 June 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 24 June 2026, providing investors with the most up-to-date insight into the company’s performance and outlook.